MOLN
Molecular Partners
MOLN
MOLN
5 hedge funds and large institutions have $17M invested in Molecular Partners in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Suvretta Capital Management
New York
|
$10.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
$6.46M |
| 3 |
UBS Group
Zurich,
Switzerland
|
$32.6K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$1.74K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
1
Suvretta Capital Management
New York
| $10.5M | +$8.65M | +1,821,494 | +455% |
|
|
BI
2
BVF Inc
San Francisco,
California
| $6.46M | +$4.34M | +910,747 | +205% |
|
|
3
UBS Group
Zurich,
Switzerland
| $32.6K | +$7.72K | +1,626 | +31% |
|
|
4
Morgan Stanley
New York
| $1.74K | -$632 | -133 | -27% |
|
5
RhumbLine Advisers
Boston,
Massachusetts
| $1.28K | – | – | – |
|